Washington Senate Bill 5594: Revised for engrossed: Concerning biosimilar medicines and interchangeable biological products.
Washington · 2025-2026 Regular Session
What it does
Revised for engrossed: Concerning biosimilar medicines and interchangeable biological products.
Latest action
By resolution, returned to Senate Rules Committee for third reading. (2026-03-12)
See how SB 5594 affects you on CapitolKey
Browse more bills · CapitolKey home